AlzeCure Pharma
2.02 SEK +4.48%1 investor is following this company
AlzeCure Pharma is a pharmaceutical company. The company focuses on research and development of drugs used for various brain diseases, with the greatest focus on Alzheimer's disease, but also on pain. The technology and research is based on its own pharmaceutical platform, where the company develops various symptom-relieving and disease-modifying drug candidates. The head office is in Huddinge.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
ALZCUR
Daily low / high price
1.955 / 2.17
SEK
Market cap
188.12M SEK
Turnover
392.82K SEK
Volume
191K
Financial calendar
Interim report
2024-05-02
General meeting
2024-05-14
Interim report
2024-08-26
Interim report
2024-11-11
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
BWG Invest Sarl | 14.1 % | 14.1 % |
Sjuenda Holding AB | 7.1 % | 7.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Extra bolagsstämma i AlzeCure Pharma AB godkände beslut om nyemission av aktier
AlzeCure offentliggör delårsrapport för januari – mars 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools